Print
Unprecedented Rise in Youth Cancer Cases
Cancers traditionally seen in older adults are now emerging in increasingly younger populations. Among them, pancreatic, colon, and ovarian cancers are appearing in teenagers and young adults, with some diagnoses occurring in children as young as eight.
Dr. Patrick Soon-Shiong, a renowned surgeon and medical researcher with over five decades of experience, has observed this shift firsthand. One especially alarming case involved a 13-year-old child presenting with metastatic pancreatic cancer, a scenario previously deemed nearly impossible.
This observation isn’t isolated. Doctors in both the United States and United Kingdom are reporting similar findings. Historically, pancreatic cancer has been linked to older age, chronic pancreatitis, and smoking.
It is rarely genetic, with only 5–10% of cases attributed to hereditary factors. Yet today, experienced clinicians are seeing these aggressive malignancies in patients under 45 and, disturbingly, even in children. Such cases were virtually nonexistent in the past.
Turbo Cancers and Aggressive Disease Progression
The term “turbo cancers” has been coined to describe these aggressive, high-grade malignancies that progress rapidly and present at advanced stages. They tend to be more virulent and are often fatal within months.
Equally concerning is the recurrence of cancers in patients who had been in remission for years. These individuals are now relapsing soon after receiving certain medical interventions, particularly booster vaccinations, though the video makes clear that causation cannot yet be definitively established without robust data.
Dr. Soon-Shiong’s observations are echoed by other oncology professionals, such as Professor Dalgleish, who has seen remission-ending relapses coincide with immune changes. These cases often lack comprehensive documentation on patients’ previous treatments, a gap that severely limits the ability to draw concrete correlations or track potential triggers.
Immune System Disruption: A New Frontier in Cancer Biology
Central to this discussion is the role of the immune system. Our bodies continuously generate abnormal cells, but they are typically eliminated by immune surveillance, primarily by cytotoxic T cells and natural killer (NK) cells.
These immune cells identify and destroy both virally infected and cancerous cells by recognizing abnormal surface proteins. However, this process requires a delicate balance between immune activation and suppression.
When suppressor cells (regulatory T cells) become overly active, they inhibit the cancer-killing action of killer cells. This leads to an environment conducive to cancer development. Dr. Soon-Shiong notes that many recent cancer cases seem to stem from this immune imbalance, with insufficient killer cell activity and excessive suppression.
Chronic Inflammation: The Invisible Carcinogen
Another key player in this immune disruption is chronic inflammation. Prolonged inflammatory states can alter the function of immune cells. For instance, neutrophils—normally phagocytic cells that consume pathogens—can transform into suppressor cells under extended inflammation.
This conversion, described by Dr. Soon-Shiong as a form of biological “yin and yang,” highlights the potential for immune cells to shift roles, contributing to tumor growth rather than combating it.
Chronic inflammation can be caused by numerous factors, including ultra-processed foods, environmental toxins, persistent infections, and even certain therapeutic interventions. The neutrophil transformation is one example of how prolonged inflammatory responses might inadvertently facilitate tumor progression rather than resolution.
Quantum Onco-Therapeutics: A Paradigm Shift
To explain this fluidity in immune cell behavior, Dr. Soon-Shiong introduces the term “quantum onco-therapeutics.” Drawing an analogy from quantum physics, particularly Schrödinger’s cat paradox, he suggests that immune cells can rapidly change states under certain conditions.
For example, a protective macrophage (M1) can become a suppressive M2 macrophage. This concept underscores the complexity of immune interactions in cancer and the urgent need to understand the full spectrum of immune cell dynamics.
Furthermore, Dr. Soon-Shiong highlights quantum entanglement as a metaphorical framework, suggesting that changes in one immune cell type can instantly influence another, even in distant bodily regions. While not a literal interpretation of quantum mechanics, the concept emphasizes the interconnectedness and rapid adaptability of immune networks.
Missed Opportunities in Immune-Driven Cancer Treatment
A critical takeaway from this discourse is the underutilization of immune-modulating therapies in mainstream oncology. Traditional treatments—surgery, radiation, and chemotherapy—aim to destroy cancer cells directly but do little to restore immune balance. According to Dr. Soon-Shiong, these approaches may neglect the underlying immune dysfunction driving cancer in the first place.
One promising alternative is an intradermal vaccine developed from cow-derived mycoplasma (Mycoplasma vaccae). This therapy has demonstrated efficacy in reactivating T-cells to combat cancer and infections. Despite its potential, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) declined its approval, limiting access to a treatment that could potentially extend life or induce remission.
The Urgent Need for Honest Data and Transparent Research
The video concludes by acknowledging the public’s demand for answers. As aggressive cancers rise among young people, a glaring lack of data collection on medical histories and prior interventions hampers efforts to trace causative factors.
With honest data, researchers might soon be able to correlate recent therapeutic interventions with cancer incidence spikes. Ultimately, the video calls for a paradigm shift in how we understand, treat, and prevent cancer.
By focusing on immune system restoration and investigating environmental and therapeutic contributors to immune imbalance, the medical community may begin to reverse the troubling trend of cancers in the young.
